Elevance Health Inc (NYSE:ELV)
$ 521.41 -22.53 (-4.14%) Market Cap: 121.19 Bil Enterprise Value: 141.41 Bil PE Ratio: 19.71 PB Ratio: 2.99 GF Score: 94/100

Anthem Inc at UBS Global Healthcare Conference Transcript

May 22, 2019 / 01:00PM GMT
Release Date Price: $277.14 (+0.03%)
Benjamin Whitman Mayo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare Facilities and Managed Care

Okay. Great. I think we're going to go ahead and get started this morning. Thanks for joining us. I'm Whit Mayo, the senior health care facilities and managed care analyst at UBS. It's my pleasure to have Pete Haytaian from Anthem; Chris Rigg runs Investor Relations and Corporate Finance.

Pete, thought we might just get into some Q&A. We've got an iPad. If anyone has any questions, feel free through the app to send your questions hopefully if I can get this thing to work. But as we talked about this morning, Pete, you've been in the Commercial segment, overseeing commercial and specialty for a little bit of time now coming from the government side. I think Anthem's identified a number of opportunities across the enterprise, I think, to improve the performance of the business. Maybe if you want to spend a minute giving some perspective on things you've learned in Commercial, where you're really focused on right now and maybe even take that into the government side.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot